Eli Lilly (LLY) Other Operating Expenses (2012 - 2019)

Eli Lilly (LLY) has reported Other Operating Expenses for 8 consecutive years, with -$151.7 million the latest figure, recorded in Q4 2019.

• Other Operating Expenses for Q4 2019 came in at -$151.7 million, up 21.24% year-over-year; the trailing twelve-month figure through Sep 2020 was -$151.7 million (up 75.39% YoY), and the FY2019 annual result was -$9.1 billion, down 10.93% from the prior year.
• Other Operating Expenses was -$151.7 million for Q4 2019 at Eli Lilly, up from -$423.9 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $5.0 billion in Q4 2016 and troughed at -$423.9 million in Q1 2019.
• Average Other Operating Expenses over 5 years is $220.6 million, with a median of -$57.4 million recorded in 2016.
• Year-over-year, Other Operating Expenses soared 3526.71% in 2016 and plunged 793.41% in 2017.
• Over 5 years, Other Operating Expenses stood at -$144.9 million in 2015, then jumped by 3526.71% to $5.0 billion in 2016, then sank by 100.89% to -$44.4 million in 2017, then tumbled by 333.78% to -$192.6 million in 2018, then rose by 21.24% to -$151.7 million in 2019.
• Per Business Quant data, the three most recent Other Operating Expenses figures were -$151.7 million in Q4 2019, -$423.9 million in Q1 2019, and -$192.6 million in Q4 2018.